1-piperonylpiperazine has been researched along with caffeic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Han, IO; Hwang, JS; Jang, M; Lee, SH; Park, JH; Park, SY | 1 |
1 other study(ies) available for 1-piperonylpiperazine and caffeic acid
Article | Year |
---|---|
A novel caffeic acid-1-piperonylpiperazine hybridization compound HBU-47 inhibits LPS-mediated inflammation in RAW264.7 macrophage cells.
Topics: Animals; Anti-Inflammatory Agents; Caffeic Acids; Cell Line; Cell Survival; Cyclooxygenase 2 Inhibitors; Cytokines; Gene Expression Regulation; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Nitric Oxide Synthase Type II; Nitrites; Piperazines; RNA, Messenger | 2014 |